Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (181-190 of 319) with videos related to

Pageof 32
Sort By:
Annals of Hematology|September 5, 2024
Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administrationRosa Toenges, Fabian Lang, Rakhshinda Ghaffar, et al.
Bone Marrow Transplantation|September 15, 2015
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantationN Jaekel, K Lieder, S Albrecht, et al.
European Journal of Haematology|July 27, 2018
Timepoints of vancomycin-resistant Enterococcus colonization predict outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantationSebastian Scheich, Sarah Weber, Rosalie König, et al.
Neuroinformatics|November 1, 2008
The NIFSTD and BIRNLex vocabularies: building comprehensive ontologies for neuroscienceWilliam J Bug, Giorgio A Ascoli, Jeffrey S Grethe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2019
Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte InfusionsMichael Merker, Emilia Salzmann-Manrique, Verena Katzki, et al.
Blood|January 22, 2015
FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferationThomas Oellerich, Sebastian Mohr, Jasmin Corso, et al.
Blood|August 3, 2012
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-Jan M Middeke, Dietrich Beelen, Michael Stadler, et al.
Cancers|February 10, 2024
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid MalignanciesFelicitas Schulz, Paul Jäger, Johanna Tischer, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 21, 2021
Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centersR Toenges, H Greinix, A Lawitschka, et al.
Journal for Immunotherapy of Cancer|April 28, 2022
Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-upEva Oswald, Daniel Bug, Anne Grote, et al.
Pageof 32

Showing results (181-190 of 319) with videos related to

Sort By:
Pageof 32
Annals of Hematology|September 5, 2024
Interventional antibiotic treatment replacing antibiotic prophylaxis during allogeneic hematopoietic stem cell transplantation is safe and leads to a reduction of antibiotic administrationRosa Toenges, Fabian Lang, Rakhshinda Ghaffar, et al.
Bone Marrow Transplantation|September 15, 2015
Efficacy and safety of deferasirox in non-thalassemic patients with elevated ferritin levels after allogeneic hematopoietic stem cell transplantationN Jaekel, K Lieder, S Albrecht, et al.
European Journal of Haematology|July 27, 2018
Timepoints of vancomycin-resistant Enterococcus colonization predict outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantationSebastian Scheich, Sarah Weber, Rosalie König, et al.
Neuroinformatics|November 1, 2008
The NIFSTD and BIRNLex vocabularies: building comprehensive ontologies for neuroscienceWilliam J Bug, Giorgio A Ascoli, Jeffrey S Grethe, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 18, 2019
Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte InfusionsMichael Merker, Emilia Salzmann-Manrique, Verena Katzki, et al.
Blood|January 22, 2015
FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferationThomas Oellerich, Sebastian Mohr, Jasmin Corso, et al.
Blood|August 3, 2012
Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and -5/5q-Jan M Middeke, Dietrich Beelen, Michael Stadler, et al.
Cancers|February 10, 2024
Smart Conditioning with Venetoclax-Enhanced Sequential FLAMSA + RIC in Patients with High-Risk Myeloid MalignanciesFelicitas Schulz, Paul Jäger, Johanna Tischer, et al.
Clinical Nutrition (Edinburgh, Scotland)|March 21, 2021
Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centersR Toenges, H Greinix, A Lawitschka, et al.
Journal for Immunotherapy of Cancer|April 28, 2022
Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-upEva Oswald, Daniel Bug, Anne Grote, et al.
Pageof 32